US2008139502A1PendingUtilityA1
Re-epithelializing pharmaceutical compositions comprising xanthan gum
Est. expiryApr 30, 2022(expired)· nominal 20-yr term from priority
A61P 43/00A61P 29/00A61P 27/02A61P 31/00A61P 25/04A61K 31/723A61K 31/715A61K 9/06A61P 17/02A61K 47/36A61K 31/573A61K 31/7036A61P 17/00A61K 31/728A61K 31/661A61K 9/0048
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the use of xanthan gum as re-epithelializing agent and, in particular, to a pharmaceutical formulation comprising xanthan gum as a re-epithelializing active principle eventually mixed with hyaluronic acid. Said use and composition speed up and improve advantageously the formation of newly grown epithelium.
Claims
exact text as granted — not AI-modified1 . Method for the treatment of epithelial wounds, which comprises administering an effective amount of xanthan gum.
2 . The method according to claim 1 , wherein xanthan gum is in admixture with hyaluronic acid.
3 . The method according to claim 1 , wherein xanthan gum is administered in association with a medicament chosen among antiinfectives, antiinflamatories, anesthetics, and mydriatics.
4 . The method according to claim 1 , wherein said epithelial wound is a wound of the corneal epithelium.
5 . The method according to claim 1 , involving promoting the proliferation of epithelial cells.
6 - 23 . (canceled)
24 . The method according to claim 2 , wherein xanthan gum is administered in association with a medicament chosen among antiinfectives, antiinflamatories, anesthetics, and mydriatics.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.